Canada· CA-DIN-02546205
AWIQLI
A insulin icodec product containing insulin icodec, registered in Canada by NOVO NORDISK CANADA INC. The same ATC class is registered in 9 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Insulin icodec is registered in 9 of 19 countries.
Countries holding a registration under ATC A10AE07 (insulin icodec), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 5 of them publish a price we can compare per daily dose
Insulin icodec · ATC A10AE07
9 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- United Statesprice
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- INSULIN ICODEC
- Manufacturer
- NOVO NORDISK CANADA INC
- Country
- Canada (CA)
- ATC code
- A10AE07
- ATC class
- Insulin icodec
- Defined daily dose
- 40 E, P
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Insulin icodec in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaAWIQLINovo Nordisk A/S, Bagsvaerd
- BelgiumAwiqli 700 U/mlNovo Nordisk
- SwitzerlandAwiqli FlexTouch 700 E/ml, Injektionslösung im FertigpenNovo Nordisk Pharma AG
- United StatesAwiqliNovo Nordisk Pharmaceutical Industries, LP
- ItalyAWIQLI*1 penna preriempita SC 700 U/ml 1,5 ml + 14 aghiNOVO NORDISK A/S
- Japanインスリン イコデク（遺伝子組換え）ノボ ノルディスク ファーマ
- IcelandAwiqliNovo Nordisk A/S*
- SwedenAwiqli 700 IE/ml Injektionsvätska, lösning i förfylld injektionspennaNovo Nordisk A/S
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Awiqli
- Norway · Awiqli
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/951ea635-eda7-4d3d-b6c1-6462e45b0180 GET /v1/drugs/951ea635-eda7-4d3d-b6c1-6462e45b0180?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02546205",
"form": "SOLUTION",
"class": "Human",
"routes": [
"SUBCUTANEOUS"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "A10AE07",
"schedule": [
"Schedule D"
],
"drug_code": "103492",
"strengths": [
"700 UNIT"
],
"ahfs_class": null,
"substances": [
"INSULIN ICODEC"
],
"product_categorization": null
}See everything about insulin icodec.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.